Portfolio

Top 10 Holdings as of 3/31/2019

Celgene Corporation Total 8.9%
Amgen Inc. 7.8%
Gilead Sciences, Inc. 7.0%
Illumina, Inc. Total 5.0%
Vertex Pharmaceuticals Incorporated Total 5.00%
Biogen Inc. Total 4.90%
Regeneron Pharmaceuticals, Inc. 4.2%
Alexion Pharmaceuticals, Inc. 3.7%
Incyte Corporation 3.1%
BioMarin Pharmaceutical Inc. 1.8%

This data is subject to change on a daily basis. Percentage of net assets.

Sub-Sector Allocation as of 3/31/2019

Biotechnology 74.6%
Pharmaceuticals 9.8%
Life Sciences Tools & Services 6.9%
Repurchase Agreement 4.4%
Health Care Equipment & Supplies _x000D_ 2.5%
Other liabilities in excess of assets 1.2%
Exchange Traded Fund 0.3%
Health Care Providers & Services 0.1%
Healthcare Services 0.1%
Medical Devices and Diagnostics 0.001

This data is subject to change on a daily basis.

Asset Allocation as of 3/31/2019

Common Stocks and Warrants 88.1%
Convertible Notes 0.4%
Convertible Preferred and Warrants 3.4%
Exchange Traded Fund 0.3%
Milestone Interests 2.2%
Short-Term Investment 4.4%
Other Liabilities In Excess Of Assets 1.2%

This data is subject to change on a daily basis. Percentage of net assets.